Keystone Heart, a Venus Medtech company, is a medical device innovator based in Tampa, FL. They are dedicated to redefining the standard of care in structural heart care through their progressive approach. Keystone Heart offers the TriGUARD 3 Cerebral Embolic Protection Device, which provides complete 3 vessel cerebral embolic protection for transcatheter aortic valve replacement (TAVR) procedures. With a focus on clinical studies and research, Keystone Heart aims to create a new standard of care in the field of structural heart care.
As a leader in the industry, Keystone Heart is committed to improving patient outcomes and reducing the risk of stroke during TAVR procedures. Their TriGUARD 3 device, currently pending FDA 510(k) clearance, is designed to offer optimal protection against cerebral embolization. With a vision to redefine the standard of care, Keystone Heart continues to innovate and develop advanced medical devices that address the needs of patients and healthcare professionals in the field of structural heart care.
Generated from the website